Teacher Retirement System of Texas Has $472,000 Holdings in ICU Medical, Inc. (NASDAQ:ICUI)

Teacher Retirement System of Texas decreased its holdings in ICU Medical, Inc. (NASDAQ:ICUI) by 27.3% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 3,400 shares of the medical instruments supplier’s stock after selling 1,277 shares during the quarter. Teacher Retirement System of Texas’ holdings in ICU Medical were worth $472,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of ICUI. Vanguard Group Inc. raised its position in shares of ICU Medical by 0.7% in the fourth quarter. Vanguard Group Inc. now owns 2,682,065 shares of the medical instruments supplier’s stock valued at $416,176,000 after buying an additional 17,805 shares in the last quarter. JPMorgan Chase & Co. increased its stake in ICU Medical by 7.4% during the 4th quarter. JPMorgan Chase & Co. now owns 708,382 shares of the medical instruments supplier’s stock worth $109,920,000 after acquiring an additional 49,108 shares during the period. Dimensional Fund Advisors LP raised its holdings in ICU Medical by 18.2% in the 4th quarter. Dimensional Fund Advisors LP now owns 539,981 shares of the medical instruments supplier’s stock valued at $83,788,000 after acquiring an additional 82,982 shares in the last quarter. Northern Trust Corp lifted its position in shares of ICU Medical by 11.1% during the 4th quarter. Northern Trust Corp now owns 402,342 shares of the medical instruments supplier’s stock valued at $62,431,000 after acquiring an additional 40,187 shares during the period. Finally, Norges Bank acquired a new stake in shares of ICU Medical during the 4th quarter worth $40,151,000. Institutional investors own 96.10% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on the company. Raymond James Financial dropped their price target on ICU Medical from $197.00 to $187.00 and set a “strong-buy” rating for the company in a research note on Friday, May 9th. KeyCorp cut their price target on shares of ICU Medical from $209.00 to $191.00 and set an “overweight” rating for the company in a report on Monday, April 21st. Needham & Company LLC reiterated a “hold” rating on shares of ICU Medical in a research report on Tuesday, April 8th. Finally, Wall Street Zen upgraded shares of ICU Medical from a “hold” rating to a “buy” rating in a research report on Sunday, May 18th. One equities research analyst has rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the stock has an average rating of “Buy” and a consensus target price of $192.67.

ICU Medical Trading Down 1.3%

Shares of ICU Medical stock opened at $124.83 on Thursday. The firm’s 50 day moving average is $133.25 and its 200 day moving average is $144.41. The firm has a market capitalization of $3.07 billion, a PE ratio of -32.59 and a beta of 0.87. ICU Medical, Inc. has a 1 year low of $117.92 and a 1 year high of $196.26. The company has a current ratio of 2.59, a quick ratio of 1.52 and a debt-to-equity ratio of 0.75.

ICU Medical (NASDAQ:ICUI) last posted its earnings results on Thursday, May 8th. The medical instruments supplier reported $1.72 earnings per share for the quarter, topping analysts’ consensus estimates of $1.23 by $0.49. ICU Medical had a negative net margin of 3.87% and a positive return on equity of 6.75%. The firm had revenue of $599.49 million for the quarter, compared to analysts’ expectations of $574.15 million. During the same quarter in the previous year, the firm posted $0.96 earnings per share. The company’s revenue was up 6.7% on a year-over-year basis. Equities research analysts forecast that ICU Medical, Inc. will post 4.11 earnings per share for the current fiscal year.

Insider Transactions at ICU Medical

In other news, insider Ben Sousa sold 2,000 shares of the company’s stock in a transaction that occurred on Thursday, May 15th. The stock was sold at an average price of $137.36, for a total value of $274,720.00. Following the completion of the transaction, the insider owned 479 shares of the company’s stock, valued at $65,795.44. This represents a 80.68% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, COO Christian B. Voigtlander sold 5,556 shares of ICU Medical stock in a transaction that occurred on Wednesday, May 14th. The stock was sold at an average price of $138.65, for a total transaction of $770,339.40. Following the sale, the chief operating officer owned 2,389 shares in the company, valued at approximately $331,234.85. This represents a 69.93% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 36,097 shares of company stock valued at $4,860,156 over the last three months. Company insiders own 1.50% of the company’s stock.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.